More about

Endometrial Cancer

News
September 19, 2023
2 min read
Save

FDA grants fast track designation to leukemia, lymphoma and endometrial cancer therapies

FDA grants fast track designation to leukemia, lymphoma and endometrial cancer therapies

The FDA announced several regulatory actions.

News
August 10, 2023
3 min read
Save

'Surprisingly low' percentage of patients with cancer undergo germline genetic testing

'Surprisingly low' percentage of patients with cancer undergo germline genetic testing

Identification of inherited genetic mutations that elevate cancer risk and may be susceptible to targeted therapies has transformed oncology care.

News
July 31, 2023
1 min read
Save

FDA expands Jemperli approval for endometrial cancer

FDA expands Jemperli approval for endometrial cancer

The FDA approved dostarlimab in combination with chemotherapy for certain women with endometrial cancer.

News
July 26, 2023
3 min read
Save

Selinexor maintenance extends PFS in endometrial cancer subgroup with high unmet need

Selinexor maintenance extends PFS in endometrial cancer subgroup with high unmet need

Selinexor maintenance after systemic therapy extended median PFS more than four times longer than placebo for women with advanced or recurrent TP53 wild-type endometrial cancer, according to phase 3 study results.

News
July 11, 2023
2 min read
Save

Similar QOL benefit for dual endometrial cancer, urinary incontinence surgery vs. cancer surgery alone

Similar QOL benefit for dual endometrial cancer, urinary incontinence surgery vs. cancer surgery alone

Among women with stress urinary incontinence and endometrial intraepithelial neoplasia or early-stage cancer, concomitant surgeries for both conditions did not improve quality of life compared with cancer surgery alone, researchers reported.

News
June 13, 2023
3 min read
Save

FDA news: License applications accepted for melanoma, endometrial cancer therapies

FDA news: License applications accepted for melanoma, endometrial cancer therapies

The FDA announced several regulatory actions the past few weeks.

News
June 03, 2023
3 min read
Save

Data confirm benefit of dostarlimab regimen for women with advanced endometrial cancer

Data confirm benefit of dostarlimab regimen for women with advanced endometrial cancer

CHICAGO — Assessment of RUBY trial outcomes by blinded independent central review confirmed the benefits of adding dostarlimab to chemotherapy for women with primary advanced or recurrent endometrial cancer.

News
May 31, 2023
2 min read
Save

Metabolically healthy and unhealthy obesity increase obesity-related cancer risk

Metabolically healthy and unhealthy obesity increase obesity-related cancer risk

Metabolically healthy and unhealthy obesity appeared associated with increased risk for various obesity-associated cancer types, according to study results presented at European Congress on Obesity.

News
May 27, 2023
1 min read
Save

Durvalumab regimens extend PFS in advanced endometrial cancer

Durvalumab regimens extend PFS in advanced endometrial cancer

The addition of durvalumab to chemotherapy — either alone or in combination with olaparib — improved outcomes for women with advanced endometrial cancer, according to the agent’s manufacturer.

News
April 19, 2023
2 min read
Save

Deep learning model predicts risk for distant recurrence of endometrial cancer

Deep learning model predicts risk for distant recurrence of endometrial cancer

A deep learning model accurately identified women with endometrial cancer at low and high risk for distant recurrence, according to research presented at American Association for Cancer Research Annual Meeting.

View more